Genialis

Boston, MA · Privately Held (backing)

Developer of an AI-driven cancer biology platform designed to predict how therapies will perform in patients. Genialis is based in Boston, MA. Its last reported valuation was $37 million in Jan 2023. It has raised $16.4 million across 2 recorded rounds; the latest was a $700,000 seed round in Dec 2025.

Last reported valuation
$37.0M
Oct 2026
Priced at
—
Total raised
$16.4M
Last round
Seed Round
Dec 2025
Cap table — not yet on record

Genialis's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genialis with a free account
  • ·Watch Genialis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Genialis

Where does Genialis's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Genialis's 2 recorded funding rounds.